Pharma's developing interest in stem cells.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20569688.
- Also identified by DOI 10.1016/j.stem.2010.05.012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Human stem cell biology is driving the promise of novel regenerative therapies into clinical trials. Although the pharmaceutical industry has embraced stem cells as tools in drug discovery, few companies have taken the risk to deliver stem cell-based medicines. Here, we evaluate the various cell-based opportunities and corporate strategies.
Medical subject headings
- Cell- and Tissue-Based Therapy
- Clinical Trials as Topic
- Drug Discovery
- Stem Cells